Skip to content

Effect of an anesthesia with remimazolam compared with propofol on liver function and immune function after laparoscopic partial hepatectomy

Effect of an anesthesia with remimazolam compared with propofol on liver function and immune function after laparoscopic partial hepatectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059715
Enrollment
Unknown
Registered
2022-05-09
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic mass lesions

Interventions

Group 2:propofol

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years, no gender requirement; BMI 18-28 kg/m2 2. Elective surgical patients with ASA grade I-II; 3. The level of transaminase is less than 2.5 times the normal value; Child-Pugh grade A.

Exclusion criteria

Exclusion criteria: 1. Those with a history of radiotherapy and chemotherapy, hormone therapy, and immune adjuvant therapy; 2. Thrombosis, bile duct obstruction of portal vein or hepatic artery thrombosis; 3. Patients with severe heart, kidney (serum creatinine > 2 mg/dl) and endocrine diseases or immune system diseases before operation; 4. Patients with adrenal insufficiency before operation; 5. Long-term use of sedative and analgesic drugs; 6. History of allergy to anesthetics; 7. Those with a history of mental illness; 8. Chronic alcoholics or recent history of heavy drinking.

Design outcomes

Primary

MeasureTime frame
Alanine aminotransferase;Aspartate aminotransferase;Total bilirubin;Prothrombin time;Activated partial thromboplastin time, APTT;Interleukin-2, IL-2;Interleukin-6, IL-6;Gamma interferon, IFN-?;NK cell, ZLK-CD16+CD56+;T lymphocytes, ZLK-CD4+/CD8+;

Secondary

MeasureTime frame
Blood pressure;Heart rate, HR;L-?-glutamyl transpeptidase, GGT;PT Internationalized Normalized Ratio, PT-INR;Thrombin time, TT;Fibrinogen, FIB;Interleukin-8, IL-8;Tumor necrosis factor alpha, TNF-a;

Countries

China

Contacts

Public ContactJin Wenjie

The First Affiliated Hospital of Nanjing Medical University

Kinwj210@126.com+86 13813043330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026